Peroxisome proliferators activate growth regulatory pathways largely via peroxisome proliferator-activated receptor α-independent mechanisms

被引:34
|
作者
Pauley, CJ [1 ]
Ledwith, BJ [1 ]
Kaplanski, C [1 ]
机构
[1] Merck Res Labs, Dept Genet & Cellular Toxicol, West Point, PA 19486 USA
关键词
growth signalling; immediate early genes; peroxisome proliferators; hepatocarcinogenesis; PPAR alpha;
D O I
10.1016/S0898-6568(01)00260-1
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Peroxisome proliferators (PPs) induce liver tumors in rodents through an unknown mechanism requiring PP-activated receptor (PPAR) alpha. Since PPs possess growth modulatory activities that may be important to their hepatocarcinogenicity, we aimed at dissociating the activation of growth signaling pathways from the PPARalpha-mediated response induced by PPs in cultured rat primary hepatocytes. Pretreatment with the differentiation-promoting agent dimethylsulfoxide (DMSO) increased PPARalpha mRNA/protein and enhanced the expression of PPARalpha-regulated genes [fatty acyl Co-A oxidase (FACO), cytochrome P450 4A1 (CyT4A1)] induced by PPs. In contrast, DMSO reduced the expression of immediate early genes (IEG) expression (c-myc, c-jun, c-fos, junB, egr-1) and inhibited mitogen-activated protein Kinase (MEK) kinase/extracellular signal-regulated kinases (ERKs) and p38 phosphorylation. Furthermore, the inhibitors Tyrphostin and PD98059 dowregulated IEG/EFKs induction and slightly enhanced the FACO/CYP4A1 response induced by the PP WY-14,643 The stimulation of signal transduction pathways by PPs can be dissociated from PPARa activation, thus suggesting that PPs could activate growth regulatory pathways largely via PPARalpha-independent mechanisms. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:351 / 358
页数:8
相关论文
共 50 条
  • [41] ENANTIOSELECTIVE ACTIVATION OF THE PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR
    BOIE, Y
    ADAM, M
    RUSHMORE, TH
    KENNEDY, BP
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1993, 268 (08) : 5530 - 5534
  • [42] Peroxisome proliferator-activated receptor γ in malignant diseases
    Wang, TT
    Xu, J
    Yu, XF
    Yang, RC
    Han, ZC
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2006, 58 (01) : 1 - 14
  • [43] Leptin and peroxisome proliferator-activated receptor gamma
    Kim, Y. S.
    Kim, H. H.
    Kang, Y. K.
    Moon, J. S.
    Kwon, S. O.
    Oh, M. K.
    Cha, I. H.
    Kim, S. Y.
    Kim, J. N.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 110 - 110
  • [44] Peroxisome proliferator-activated receptor β/δ goes vascular
    Bishop-Bailey, David
    CIRCULATION RESEARCH, 2008, 102 (02) : 146 - 147
  • [45] Peroxisome proliferator-activated receptor γ (PPARγ) and immunoregulation:: Enhancement of regulatory T cells through PPARγ-dependent and -independent mechanisms
    Wohlfert, Elizabeth A.
    Nichols, Frank C.
    Nevins, Erin
    Clark, Robert B.
    JOURNAL OF IMMUNOLOGY, 2007, 178 (07): : 4129 - 4135
  • [46] Peroxisome proliferator-activated receptor gamma in osteoarthritis
    Fahmi, Hassan
    Martel-Pelletier, Johanne
    Pelletier, Jean-Pierre
    Kapoor, Mohit
    MODERN RHEUMATOLOGY, 2011, 21 (01) : 1 - 9
  • [47] Role of peroxisome proliferator-activated receptor α in atherosclerosis
    Cao, Heng
    Wen, Gao
    Li, Hongli
    MOLECULAR MEDICINE REPORTS, 2014, 9 (05) : 1755 - 1760
  • [48] Peroxisome proliferator-activated receptor ligands in atherosclerosis
    Viles-Gonzalez, JF
    Choi, BG
    Fuster, V
    Badimon, JJ
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2004, 13 (11) : 1393 - 1403
  • [49] LOCALIZATION OF THE PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR IN THE BRAIN
    KAINU, T
    WIKSTROM, AC
    GUSTAFSSON, JA
    PELTOHUIKKO, M
    NEUROREPORT, 1994, 5 (18) : 2481 - 2485
  • [50] The pleiotropic functions of peroxisome proliferator-activated receptor γ
    Marie-Bernard Debril
    Jean-Paul Renaud
    Lluis Fajas
    Johan Auwerx
    Journal of Molecular Medicine, 2001, 79 : 30 - 47